Innovating for a Better Future
Pioneering Health and Technology
At RDI, we harness research and innovation to advance biotechnology, healthcare solutions, and space medicine for a healthier tomorrow.
About RDI
RDI (Research Discovery Innovation) develops biotechnology and medical research programs focused on biological resilience and protection in both clinical and extreme environments.
Our mission is to translate scientific discovery into practical development activities through international collaboration—spanning oncology, radiation-related research, and space-relevant health challenges.
We work with academic and institutional partners to advance research, generate evidence, and build credible development pathways.
How RDI operates
RDI is led by a core team spanning translational research, pharmacology, radiation biology, and program development. We work with a network of academic and institutional collaborators across the U.S. and Europe to advance research and development activities.
Key Collaborators & Partners
RDI collaborates with academic and institutional partners across the U.S. and Europe. Selected collaborators include:
NIAID (USA) – Radiation countermeasure research collaboration
SRI International (USA) – Biosciences research support
Lovelace Biomedical Research Institute (USA) – Preclinical research and testing
University of Illinois Chicago (USA) – Clinical and translational research
University of Maryland Baltimore (USA) – Biochemical and pharmacological studies
Maastricht University (Netherlands) – Biomedical engineering and regenerative research
SCK CEN (Belgium) – Radiation biology and space-relevant research
Space Applications Services (Belgium) – Space medicine and human health research
